• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于脑部靶向的脂质纳米颗粒 III. 长期稳定性和体内毒性。

Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity.

机构信息

Dipartimento di Chimica e Tecnologia del Farmaco, University of Perugia, via del Liceo 1, 06123 Perugia, Italy.

出版信息

Int J Pharm. 2013 Sep 15;454(1):316-23. doi: 10.1016/j.ijpharm.2013.06.037. Epub 2013 Jul 4.

DOI:10.1016/j.ijpharm.2013.06.037
PMID:23832009
Abstract

PURPOSE

The aim of the work was to assess the long-term stability and the safety of lipid nanoparticles intended for brain drug delivery.

METHODS

Lipid nanoparticles, prepared by high pressure homogenization, were stored at room temperature and 4°C and monitored for their mean hydrodynamic diameter and Gaussian distribution width over time. Cetylpalmitate and polysorbate(®) 80 chemical integrity were investigated by nuclear magnetic resonance on diagnostic signals. Nanoparticle toxicity was assessed in chicken embryos by chorioallantoic membrane assay and in rodents by brain histological evaluation.

RESULTS

Data showed nanoparticle stability at 4°C over a period of time of 4 years with only a limited particle size increase while at room temperature destabilization was observed after 9 months. Nuclear magnetic resonance investigation confirmed the absence (<5%) of chemical degradation of the lipid matrix and the surfactant after 4 years of storage at 4°C. Chorioallantoic membrane assay and rat brain histology showed the absence of acute toxicity corroborating previously published data.

CONCLUSIONS

Cetylpalmitate nanoparticle long-term physical and chemical stability, together with the in vivo safety, corroborate the existing evidences of the high value of colloidal lipids as parenteral formulations and carriers for brain drug delivery.

摘要

目的

本研究旨在评估用于脑部药物递送的脂质纳米粒的长期稳定性和安全性。

方法

采用高压均质法制备脂质纳米粒,在室温及 4°C 下储存,实时监测其平均水动力直径和高斯分布宽度。通过核磁共振技术对诊断信号进行检测,以评估十六烷酸鲸蜡酯和聚山梨酯(®)80 的化学完整性。通过鸡胚绒毛尿囊膜实验和啮齿动物脑组织学评估来评估纳米粒的毒性。

结果

数据显示,脂质纳米粒在 4°C 下可稳定 4 年以上,粒径仅略有增加,而在室温下,9 个月后就会发生不稳定。核磁共振研究证实,在 4°C 下储存 4 年后,脂质基质和表面活性剂的化学降解率<5%。鸡胚绒毛尿囊膜实验和大鼠脑组织学研究表明,纳米粒无急性毒性,这与先前发表的数据相符。

结论

十六烷酸鲸蜡酯纳米粒的长期物理和化学稳定性,以及体内安全性,证实了胶体脂质作为注射制剂和脑部药物递送载体的高价值。

相似文献

1
Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity.用于脑部靶向的脂质纳米颗粒 III. 长期稳定性和体内毒性。
Int J Pharm. 2013 Sep 15;454(1):316-23. doi: 10.1016/j.ijpharm.2013.06.037. Epub 2013 Jul 4.
2
A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique.采用正丁醇作为辅助表面活性剂,根据 o/w 微乳液猝灭技术制备固体脂质纳米粒的新方法。
Chem Phys Lipids. 2013 Sep;174:32-8. doi: 10.1016/j.chemphyslip.2013.05.001. Epub 2013 Jun 3.
3
Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.含有混合脂质核心和极性异质脂质的固体脂质纳米分散体:表征
Eur J Pharm Biopharm. 2007 Aug;67(1):48-57. doi: 10.1016/j.ejpb.2006.12.004. Epub 2006 Dec 16.
4
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.通过基于胆酸钠 - 磷脂酰胆碱的混合胶束负载胰岛素的固体脂质纳米粒:制备与表征
Int J Pharm. 2007 Aug 1;340(1-2):153-62. doi: 10.1016/j.ijpharm.2007.03.009. Epub 2007 Mar 12.
5
Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.用杂脂质模板化同脂质制备的表面改性固体脂质纳米容器的研究。
Int J Pharm. 2007 Apr 4;334(1-2):179-89. doi: 10.1016/j.ijpharm.2006.10.032. Epub 2006 Oct 28.
6
Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.静脉注射后喜树碱负载固体脂质纳米粒在大鼠体内的脑靶向作用
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):488-502. doi: 10.1016/j.ejpb.2013.08.011. Epub 2013 Aug 27.
7
Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.多变量设计评价脂质和表面活性剂组成对脂质纳米粒优化的影响。
Eur J Pharm Sci. 2012 Apr 11;45(5):613-23. doi: 10.1016/j.ejps.2011.12.015. Epub 2012 Jan 10.
8
Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.用于改善抗真菌治疗的伊曲康唑负载型固体脂质纳米粒系统的设计与评价
Pak J Pharm Sci. 2009 Apr;22(2):131-8.
9
Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.司他夫定固体脂质纳米粒的制备及稳定性——从实验室到工业规模。
Int J Pharm. 2011 Sep 20;416(2):461-70. doi: 10.1016/j.ijpharm.2010.08.014. Epub 2010 Aug 18.
10
Non-destructive methods of characterization of risperidone solid lipid nanoparticles.利培酮固体脂质纳米粒的非破坏性特征描述方法。
Eur J Pharm Biopharm. 2010 Sep;76(1):127-37. doi: 10.1016/j.ejpb.2010.05.003. Epub 2010 May 12.

引用本文的文献

1
Chicken embryo model for acute toxicological and antitumor efficacy evaluation of lipid nanocarrier containing doxorubicin.用于含阿霉素脂质纳米载体急性毒理学和抗肿瘤疗效评估的鸡胚模型
Int J Pharm X. 2023 Jun 24;6:100193. doi: 10.1016/j.ijpx.2023.100193. eCollection 2023 Dec 15.
2
Toxicological Analysis by Assessment of Vascularization and Cell Viability Using the Chicken's Chorioallantoic Membrane (CAM Assay).利用鸡胚尿囊膜(CAM 分析)评估血管生成和细胞活力进行毒理学分析。
Methods Mol Biol. 2023;2644:403-421. doi: 10.1007/978-1-0716-3052-5_26.
3
Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation.
用于中枢神经系统疾病的肠胃外脂质纳米颗粒:整合临床前评估的各个方面以实现更有效的临床转化。
Pharmaceutics. 2023 Jan 29;15(2):443. doi: 10.3390/pharmaceutics15020443.
4
Essential Oil-Loaded NLC for Potential Intranasal Administration.用于潜在鼻内给药的载精油纳米脂质载体
Pharmaceutics. 2021 Jul 28;13(8):1166. doi: 10.3390/pharmaceutics13081166.
5
The Chorioallantoic Membrane Assay in Nanotoxicological Research-An Alternative for Experimentation.纳米毒理学研究中的绒毛尿囊膜试验——一种实验替代方法
Nanomaterials (Basel). 2020 Nov 24;10(12):2328. doi: 10.3390/nano10122328.
6
Monitoring of tumor growth and vascularization with repetitive ultrasonography in the chicken chorioallantoic-membrane-assay.利用重复性超声检查监测鸡胚绒毛尿囊膜实验中的肿瘤生长和血管生成。
Sci Rep. 2020 Oct 29;10(1):18585. doi: 10.1038/s41598-020-75660-y.
7
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages.固体脂质纳米粒和纳米结构脂质载体作为新型药物递送系统:应用、优点和缺点。
Res Pharm Sci. 2018 Aug;13(4):288-303. doi: 10.4103/1735-5362.235156.
8
Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.采用实验设计通过高压均质法制备用于脑靶向和提高生物利用度的依非韦伦固体脂质纳米粒的系统方法及优化
Biomed Res Int. 2017;2017:5984014. doi: 10.1155/2017/5984014. Epub 2017 Jan 23.
9
Enhancing Anticancer Effect of Gefitinib across the Blood-Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80.使用一种α-螺旋细胞穿透肽或谷胱甘肽及吐温80修饰的脂质体增强吉非替尼在血脑屏障模型中的抗癌效果。
Int J Mol Sci. 2016 Nov 29;17(12):1998. doi: 10.3390/ijms17121998.
10
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.通过天然抗氧化剂的新型纳米液滴制剂治疗多发性硬化症动物模型。
Int J Nanomedicine. 2015 Nov 20;10:7165-74. doi: 10.2147/IJN.S92704. eCollection 2015.